NanoViricides, Inc. (NYSE American: NNVC) announced it entered into a securities purchase agreement with a single fundamental institutional investor for the purchase and sale of 2,516,339 common shares, or pre-funded warrants in lieu thereof, together with warrants to purchase an equal number of common shares. The registered direct offering is expected to generate approximately $3.8 million in gross proceeds before placement agent fees and other expenses. Each full warrant will have an exercise price of $1.75 per share and expire five and a half years after issuance.
The offering is expected to close on or about July 27, 2026, subject to customary closing conditions. D. Boral Capital LLC is serving as exclusive placement agent.
To view the full press release, visit https://nnw.fm/2qH5W
NOTE TO INVESTORS: The latest news and updates relating to NNVC are available in the company’s newsroom at https://nnw.fm/NNVC
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or republished: http://NNW.fm/Disclaimer